These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 12865321

  • 1. Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells.
    Spitzweg C, Scholz IV, Bergert ER, Tindall DJ, Young CY, Göke B, Morris JC.
    Endocrinology; 2003 Aug; 144(8):3423-32. PubMed ID: 12865321
    [Abstract] [Full Text] [Related]

  • 2. Dexamethasone enhances the cytotoxic effect of radioiodine therapy in prostate cancer cells expressing the sodium iodide symporter.
    Scholz IV, Cengic N, Göke B, Morris JC, Spitzweg C.
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1108-16. PubMed ID: 15001595
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.
    Spitzweg C, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC.
    Cancer Res; 2000 Nov 15; 60(22):6526-30. PubMed ID: 11103823
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enhanced expression of adenovirus-mediated sodium iodide symporter gene in MCF-7 breast cancer cells with retinoic acid treatment.
    Lim SJ, Paeng JC, Kim SJ, Kim SY, Lee H, Moon DH.
    J Nucl Med; 2007 Mar 15; 48(3):398-404. PubMed ID: 17332617
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
    Cengic N, Baker CH, Schütz M, Göke B, Morris JC, Spitzweg C.
    J Clin Endocrinol Metab; 2005 Aug 15; 90(8):4457-64. PubMed ID: 15941870
    [Abstract] [Full Text] [Related]

  • 11. Application of 188rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression.
    Willhauck MJ, Sharif Samani BR, Gildehaus FJ, Wolf I, Senekowitsch-Schmidtke R, Stark HJ, Göke B, Morris JC, Spitzweg C.
    J Clin Endocrinol Metab; 2007 Nov 15; 92(11):4451-8. PubMed ID: 17698909
    [Abstract] [Full Text] [Related]

  • 12. Approaches to gene therapy with sodium/iodide symporter.
    Spitzweg C, Morris JC.
    Exp Clin Endocrinol Diabetes; 2001 Nov 15; 109(1):56-9. PubMed ID: 11573142
    [Abstract] [Full Text] [Related]

  • 13. Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone.
    Willhauck MJ, Sharif-Samani B, Senekowitsch-Schmidtke R, Wunderlich N, Göke B, Morris JC, Spitzweg C.
    Breast Cancer Res Treat; 2008 May 15; 109(2):263-72. PubMed ID: 17636401
    [Abstract] [Full Text] [Related]

  • 14. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
    Willhauck MJ, Sharif Samani BR, Klutz K, Cengic N, Wolf I, Mohr L, Geissler M, Senekowitsch-Schmidtke R, Göke B, Morris JC, Spitzweg C.
    Gene Ther; 2008 Feb 15; 15(3):214-23. PubMed ID: 17989705
    [Abstract] [Full Text] [Related]

  • 15. Differential regulation of sodium/iodide symporter gene expression by nuclear receptor ligands in MCF-7 breast cancer cells.
    Kogai T, Kanamoto Y, Li AI, Che LH, Ohashi E, Taki K, Chandraratna RA, Saito T, Brent GA.
    Endocrinology; 2005 Jul 15; 146(7):3059-69. PubMed ID: 15817668
    [Abstract] [Full Text] [Related]

  • 16. Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line.
    Kogai T, Schultz JJ, Johnson LS, Huang M, Brent GA.
    Proc Natl Acad Sci U S A; 2000 Jul 18; 97(15):8519-24. PubMed ID: 10890895
    [Abstract] [Full Text] [Related]

  • 17. In vivo sodium iodide symporter gene therapy of prostate cancer.
    Spitzweg C, Dietz AB, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC.
    Gene Ther; 2001 Oct 18; 8(20):1524-31. PubMed ID: 11704812
    [Abstract] [Full Text] [Related]

  • 18. Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line.
    Jeong H, Kim YR, Kim KN, Choe JG, Chung JK, Kim MK.
    Nucl Med Biol; 2006 Oct 18; 33(7):875-82. PubMed ID: 17045167
    [Abstract] [Full Text] [Related]

  • 19. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
    Schmutzler C, Winzer R, Meissner-Weigl J, Köhrle J.
    Biochem Biophys Res Commun; 1997 Nov 26; 240(3):832-8. PubMed ID: 9398654
    [Abstract] [Full Text] [Related]

  • 20. Retinoic acid and tributyrin induce in-vitro radioiodine uptake and inhibition of cell proliferation in a poorly differentiated follicular thyroid carcinoma.
    Zhang M, Guo R, Xu H, Zhang M, Li B.
    Nucl Med Commun; 2011 Jul 26; 32(7):605-10. PubMed ID: 21471848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.